Slide
The world’s most advanced bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.

Kerato utilise world-class expertise in tissue engineering to develop bio-engineered corneal products for medical and research applications.

Kerato utilise world-class expertise in tissue engineering to develop bio-engineered corneal products for medical and research applications.

Slide
The world’s most advanced bio-engineered, biomimetic cornea.
The world’s most advanced
bio-engineered, biomimetic cornea.
Our proprietary platform technology allows the fabrication of a fully biosynthetic human cornea in-vitro medical device that reproduces the highly complex nanostructure, molecular composition, shape, transparency, and functional properties of the native human-corneal stroma.

The world’s most advanced
bio-engineered, biomimetic
cornea.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Slide

About Kerato
About Kerato
About Kerato

Our company specializes in the development of bioengineered solutions for tissue repair and regeneration applications. Multi-patented technology combined with extensive expertise in tissue engineering and biomaterials, enables us to develop bio-equivalent tissue that reproduces the complex structure and function of corneal tissue.

Our focus is to provide innovative solutions that address medical challenges through our portfolio of Regenerative Therapies, and bioequivalent tissues that can be used to support commercial research and development activities.

About Kerato
About Kerato

Our company specializes in the development of bioengineered solutions for tissue repair and regeneration applications. Multi-patented technology combined with extensive expertise in tissue engineering and biomaterials, enables us to develop bio-equivalent tissue that reproduces the complex structure and function of corneal tissue.

Our focus is to provide innovative solutions that address medical challenges through our portfolio of Regenerative Therapies, and bioequivalent, scaffold-free tissue that can be used to support commercial research and development activities.

Corneal Regenerative
Therapies

Kerato is developing next generation medical devices and therapies that offer novel alternatives to corneal transplantation, including corneal trauma /perforation repair, which will address the global shortage of donor tissue to treat corneal blindness

Corneal Equivalent Tissue

We are at the forefront of bioengineering, developing advanced, corneal equivalent tissue that supports the growth of cells and facilitates efficient drug transportation.

Helping to reduce the 13m Patients Waiting
for Cornea Transplants

Helping to reduce reliance
on Animal Testing

Want to learn more about what we do, and how we could work with your business or research group? Get in touch!

Investment Partner
Scientific Partner
© Kerato Limited 2024. All Rights Reserved 
crossmenu